Bio-Rad Laboratories, Inc. Stock Deutsche Boerse AG
Stocks
BUWA
US0905722072
Medical Equipment, Supplies & Distribution
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 246.00 EUR | -2.61% |
|
-3.15% | -3.83% |
| Market Cap | 7.74B 6.69B 6.16B 5.77B 10.81B 736B 10.98B 72.78B 28.38B 358B 29.06B 28.45B 1,241B | P/E Ratio 2026 * |
34.4x | P/E Ratio 2027 * | 33.6x |
|---|---|---|---|---|---|
| Enterprise Value | 7B 6.04B 5.57B 5.21B 9.77B 665B 9.92B 65.74B 25.63B 324B 26.25B 25.69B 1,121B | EV / Sales 2026 * |
2.72x | EV / Sales 2027 * | 2.57x |
| Free-Float |
60.28% | Yield 2026 * |
-
| Yield 2027 * | - |
Last Transcript: Bio-Rad Laboratories, Inc.
| 1 day | -2.61% | ||
| 1 week | -3.15% | ||
| Current month | -7.80% | ||
| 1 month | +18.04% | ||
| 3 months | +7.47% | ||
| 6 months | -6.04% | ||
| Current year | -3.83% |
| 1 week | 246 |  | 255.8 |
| 1 month | 209.6 | | 272.6 |
| Current year | 204.6 | | 278.4 |
| 1 year | 195.45 | | 294.7 |
| 3 years | 187.35 | | 383.8 |
| 5 years | 187.35 | | 700 |
| 10 years | 118.25 | | 700 |
| Manager | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CEO | Chief Executive Officer | 76 | 2002-12-31 |
| President | 61 | 2024-09-08 | |
Roop Lakkaraju
DFI | Director of Finance/CFO | 55 | 2024-04-14 |
| Director | Title | Age | Since |
|---|---|---|---|
Norman Schwartz
CHM | Chairman | 76 | 2011-12-31 |
Jeffrey Edwards
BRD | Director/Board Member | 65 | 2017-04-24 |
Gregory Hinckley
BRD | Director/Board Member | 79 | 2017-04-24 |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | -2.61% | -3.15% | - | - | 7.74B | |
| -1.64% | -3.17% | -34.98% | -13.43% | 154B | |
| -0.16% | -1.80% | -8.10% | -6.47% | 103B | |
| +0.07% | +2.41% | -4.69% | +56.67% | 54.8B | |
| +3.00% | +0.30% | +58.58% | +48.55% | 55.22B | |
| -0.75% | -3.25% | -15.08% | -41.85% | 40.3B | |
| -1.40% | +8.93% | - | - | 30.96B | |
| +0.16% | +3.44% | -8.07% | -40.16% | 29.08B | |
| -0.46% | +4.55% | +48.18% | -8.10% | 23.23B | |
| -2.85% | -3.53% | -15.70% | -1.83% | 20.25B | |
| Average | -0.66% | +1.02% | +2.52% | -0.83% | 56.71B | |
| Weighted average by Cap. | -0.49% | -0.31% | -6.82% | -0.05% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | 2.57B 2.22B 2.04B 1.91B 3.58B 244B 3.64B 24.13B 9.41B 119B 9.63B 9.43B 411B | 2.63B 2.28B 2.1B 1.96B 3.68B 250B 3.74B 24.76B 9.65B 122B 9.89B 9.68B 422B |
| Net income | 225M 194M 179M 168M 314M 21.37B 319M 2.11B 824M 10.4B 844M 826M 36.02B | 230M 198M 183M 171M 321M 21.83B 326M 2.16B 842M 10.63B 862M 844M 36.8B |
| Net Debt | -749M -647M -596M -558M -1.05B -71.19B -1.06B -7.04B -2.74B -34.65B -2.81B -2.75B -120B | -965M -834M -768M -719M -1.35B -91.76B -1.37B -9.07B -3.54B -44.66B -3.62B -3.55B -155B |
| Date | Price | Change |
|---|---|---|
| 26-06-12 | 246.00 € | -2.61% |
| 26-06-11 | 252.60 € | -0.16% |
| 26-06-10 | 253.00 € | -1.09% |
| 26-06-09 | 255.80 € | +0.95% |
| 26-06-08 | 253.40 € | -0.24% |
Trader
This super rating is the result of a weighted average of the rankings based on the following ratings: Valuation (Composite), EPS Revisions (4 months), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Investor
This super composite rating is the result of a weighted average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), EPS Revisions (1 year), and Visibility (Composite). We recommend that you carefully review the associated descriptions.
Global
This composite rating is the result of an average of the rankings based on the following ratings: Fundamentals (Composite), Valuation (Composite), Financial Estimates Revisions (Composite), Consensus (Composite) and Visibility (Composite). The company must be covered by at least 4 of these 5 ratings for the calculation to be carried out. We recommend that you carefully review the associated descriptions.
Quality
This composite rating is the result of an average of rankings based on the following ratings: Returns (Composite), Profitability (Composite) and Quality of Financial Reporting (Composite), and Financial Health (Composite). The company must be covered by at least 2 of these 3 ratings for the calculation to be performed. We recommend that you carefully read the associated descriptions.
ESG MSCI
The MSCI ESG score assesses a company’s environmental, social, and governance practices relative to its industry peers. Companies are rated from CCC (laggard) to AAA (leader). This rating helps investors incorporate sustainability risks and opportunities into their investment decisions.
Quarterly revenue - Rate of surprise
- Stock Market
- Stocks
- BIO Stock
- BUWA Stock
Select your edition
All financial news and data tailored to specific country editions
